A detailed history of Massmutual Trust CO Fsb transactions in Natera, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 30 shares of NTRA stock, worth $4,931. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 22 36.36%
Holding current value
$4,931
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

BUY
$97.75 - $129.67 $782 - $1,037
8 Added 36.36%
30 $3,000
Q2 2024

Jul 02, 2024

BUY
$85.28 - $112.6 $341 - $450
4 Added 22.22%
22 $2,000
Q1 2024

Apr 09, 2024

BUY
$59.21 - $92.9 $592 - $929
10 Added 125.0%
18 $1,000
Q4 2023

Jan 03, 2024

BUY
$37.55 - $62.64 $300 - $501
8 New
8 $0
Q1 2022

Apr 08, 2022

SELL
$30.32 - $91.33 $212 - $639
-7 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$86.26 - $119.0 $603 - $833
7 New
7 $1,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.9B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.